Alpha Wave Global, LP - 06 Feb 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Reporting relationship: 10%+ Owner
Issuer ticker: ANRO
Reported as of: 06 Feb 2024
Net transaction value: +$9,600,000
SEC form: 4
Accepted by SEC: 08 Feb 2024, 16:32:33 UTC
Prior SEC filing: 30 Mar 2023
Source filing: View source filing
Reporting owner signature: Alpha Wave Global, LP, By: /s/ Richard Gerson, Chairman and CIO

Key filing fact

Alpha Wave Global, LP filed Form 4 for Alto Neuroscience, Inc. (ANRO) on 08 Feb 2024.

Key facts

This page summarizes Alpha Wave Global, LP's Form 4 filing for Alto Neuroscience, Inc. (ANRO).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Feb 2024, 16:32.

Change

Previous filing in this sequence was filed on 30 Mar 2023.
Current net transaction value: +$9,600,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANRO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,962,995
Change %
Price
Shares after: 1,962,995
Date: 06 Feb 2024
Ownership: See footnotes
Footnotes: F1, F3, F4

ANRO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,144,762
Change %: +58%
Price
Shares after: 3,107,757
Date: 06 Feb 2024
Ownership: See footnotes
Footnotes: F2, F3, F4

ANRO transaction

Common Stock

Purchase

Transaction value: $9,600,000
Shares: +600,000
Change %: +19%
Price: $16.00^*
Shares after: 3,707,757
Date: 06 Feb 2024
Ownership: See footnotes
Footnotes: F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANRO transaction Derivative

Series B Convertible Preferred Stock (Series B Preferred)

Conversion of derivative security

Transaction value: $0
Shares: -1,962,995
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Feb 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 1,962,995
Exercise price
Footnotes: F1, F3, F4

ANRO transaction Derivative

Series C Convertible Preferred Stock (Series C Preferred)

Conversion of derivative security

Transaction value: $0
Shares: -1,144,763
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Feb 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 1,144,763
Exercise price
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Immediately prior to the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into shares of common stock on a 2.1226069 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.

Footnote F2

Immediately prior to the closing of the Issuer's initial public offering, each share of Series C Preferred Stock automatically converted into shares of common stock on a 2.2241 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.

Footnote F3

Securities held by Alpha Wave Ventures II, LP ("Alpha Wave Ventures"). Alpha Wave Ventures GP, Ltd ("Alpha Wave Ventures GP") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP ("Alpha Wave") and Lunate Holding RSC LTD ("Lunate"). Lunate is a subsidiary of Chimera Investment LLC ("Chimera," together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the "Reporting Persons"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors.

Footnote F4

For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose.